A federal judge blocked parts of HHS's vaccine policy changes, siding with medical groups against Robert F. Kennedy Jr.'s agenda.

Vaccine programmes are being challenged by rising misinformation and an uncertain pipeline for research funding, the World ...

A person poses with a dose of Novavax Nuvaxovid COVID-19 vaccine in this illustration picture taken in Schwenksville, Pennsylvania, U.S. October 2, 2025. REUTERS/Hannah Beier/Illustration March 16 ...

Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look ...

As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the therapeutics industry, ...

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.

Two physicians with somewhat contrasting views on vaccines are among the potential candidates the Trump administration is considering as its pick to lead the U.S. Centers for Disease Control and ...

A federal court injunction put a check on Health Secretary Robert F. Kennedy Jr.'s rapid assault on U.S. vaccine recommendations, but months of turmoil and misinformation have sown doubt about ...

RNA vaccines saved millions of lives during COVID-19 but have limitations like waning immunity and complex production. Scientists are now testing a new platform called DoriVac, which uses folded DNA ...

A fourth dose of bivalent or monovalent BA.1-adapted BNT162b2 vaccines was safe and elicited robust neutralizing responses in adults aged 18 to 55 years.

The vaccine was previously approved in the US to prevent LRTD related to RSV infection in adults 60 years or older and ...